Search Results - "BARUTEAU, J"

Refine Results
  1. 1

    Delivering efficient liver-directed AAV-mediated gene therapy by Baruteau, J, Waddington, S N, Alexander, I E, Gissen, P

    Published in Gene therapy (01-05-2017)
    “…Adeno-associated virus vectors (AAV) have become the leading technology for liver-directed gene therapy. After the pioneering trials using AAV2 and AAV8…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pyruvate carboxylase deficiency type C; variable presentation and beneficial effect of triheptanoin by Bernhardt, I., Van Dorp, L., Dixon, M., McSweeney, M., Gan, C., Baruteau, J., Chakrapani, A.

    Published in JIMD reports (01-01-2024)
    “…Pyruvate carboxylase is a mitochondrial enzyme essential for the tricarboxylic acid cycle (TCA), gluconeogenesis and fatty‐acid synthesis. Pyruvate carboxylase…”
    Get full text
    Journal Article
  4. 4

    Mourning a chronic disease: diagnostic error experienced by two families by Baruteau, J, Cascales, T

    “…We report on two pediatric cases with a diagnosis of hereditary metabolic disease established for several years and secondarily disproved. Retrospective…”
    Get full text
    Journal Article
  5. 5

    New insights into perinatal hemochromatosis by Baruteau, J, Heissat, S, Collardeau-Frachon, S, Debray, D, Broué, P, Guigonis, V

    “…Perinatal hemochromatosis (PH) includes neonatal acute liver failure (ALF) with cirrhosis and extrahepatic iron overload sparing the reticuloendothelial…”
    Get full text
    Journal Article
  6. 6

    Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management by Feillet, F, Ogier, H, Cheillan, D, Aquaviva, C, Labarthe, F, Baruteau, J, Chabrol, B, de Lonlay, P, Valayanopoulos, V, Garnotel, R, Dobbelaere, D, Briand, G, Jeannesson, E, Vassault, A, Vianey-Saban, C

    “…MCAD deficiency is the most common fatty acid oxidation disorder, with the prevalence varying from 1/10,000 to 1/27,000 in the countries adjacent to France. As…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8

    Sjögren-Larsson syndrome: 2 case reports by Galoin-Bertail, C, Ogier de Baulny, H, Wanders, R, Schiff, M, Bellavoine, V, Mlika, A, Benoist, G, Baruteau, J

    “…Sjögren-Larsson syndrome (SLS) is a neurocutaneous autosomal recessive disease caused by fatty aldehyde dehydrogenase (FADH) deficiency. This enzyme is…”
    Get full text
    Journal Article
  9. 9

    Faire le deuil d’une maladie chronique : vécu de l’erreur diagnostique par deux familles by Baruteau, J., Cascales, T.

    “…Nous rapportons deux observations pédiatriques pour lesquelles un diagnostic de maladie héréditaire du métabolisme établi depuis plusieurs années a été…”
    Get full text
    Journal Article
  10. 10

    Prise en charge psychologique des enfants avec une maladie héréditaire du métabolisme by Cascales, T., Baruteau, J.

    “…Les maladies héréditaires du métabolisme (MHM) sont des maladies génétiques rares dont l’âge de révélation est fréquemment la petite enfance. Ces pathologies…”
    Get full text
    Journal Article
  11. 11

    Chorioangiomatosis: a rare etiology of nonimmune hydrops fetalis. Obstetric and pediatric implications for patient care by Baruteau, J, Joomye, R, Muller, J-B, Vinceslas, C, Baraton, L, Joubert, M, Paumier, A, Roze, J-C

    “…We report a case of chorioangiomatosis with hydrops fetalis as a complication. Hydrops fetalis associated with fetal distress led to preterm birth at 33 GW…”
    Get full text
    Journal Article
  12. 12

    Successful Desensitisation in a Patient with CRIM-Positive Infantile-Onset Pompe Disease by Baruteau, J., Broomfield, A., Crook, V., Finnegan, N., Harvey, K., Burke, D., Burch, M., Shepherd, G., Vellodi, A.

    Published in JIMD Reports - Volume 12 (01-01-2014)
    “…Pompe disease (PD) is a severe life-threatening disease in which enzyme replacement therapy (ERT) with alglucosidase alfa is the only treatment available…”
    Get full text
    Book Chapter Journal Article
  13. 13

    G469 Developmental delay in a young infant with non-classical combined malonic and methyl malonic aciduria (CMAMMA) caused by homozygous missense mutation in ACSF3 gene by Dayasiri, MBKC, Goh, E, Kodagali, S, Baruteau, J, Anand, G

    Published in Archives of disease in childhood (01-10-2020)
    “…IntroductionAcylCoA synthetase family member 3 (ACSF3) activates malonylCoA and methymalonylCoA into their respective thioesters. ACSF3 deficiency causes…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Nouveaux concepts dans l’hémochromatose périnatale by Baruteau, J., Heissat, S., Collardeau-Frachon, S., Debray, D., Broué, P., Guigonis, V.

    “…L’hémochromatose périnatale (HP) est une maladie à début anténatal caractérisée par une insuffisance hépatocellulaire aiguë (IHA) néonatale avec cirrhose et…”
    Get full text
    Journal Article
  18. 18

    Le syndrôme de Sjögren-Larsson : à propos de 2 cas by Galoin-Bertail, C., Ogier de Baulny, H., Wanders, R., Schiff, M., Bellavoine, V., Mlika, A., Benoist, G., Baruteau, J.

    “…Le syndrome de Sjögren-Larsson (SLS) est une maladie neuro-cutanée autosomique récessive liée à une anomalie du métabolisme des lipides par déficit en…”
    Get full text
    Journal Article
  19. 19
  20. 20

    La chorioangiomatose : une cause rare d’anasarque fœtoplacentaire non immune. Implications pratiques obstétrico-pédiatriques by Baruteau, J., Joomye, R., Muller, J.-B., Vinceslas, C., Baraton, L., Joubert, M., Paumier, A., Roze, J.-C.

    “…We report a case of chorioangiomatosis with hydrops fetalis as a complication. Hydrops fetalis associated with fetal distress led to preterm birth at 33 GW…”
    Get full text
    Journal Article